Summarized by Masters of Longevity from PR Newswire.
Qutenza produced greater average pain reduction than control over weeks 2–12 and 2–42.
Key Takeaways
- Qutenza was reported to reduce average pain intensity versus control.
- Week-12 difference favoured Qutenza but was not statistically significant.
- Safety findings were reported as consistent with prior Qutenza trials.
